Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome

  • D. Werber
  • A. Fruth
  • U. Buchholz
  • R. Prager
  • M. H. Kramer
  • A. Ammon
  • H. Tschäpe
Article

Abstract

The aim of this study was to investigate the association between Shiga toxin-producing Escherichia coli (STEC) O157 and the simultaneous presence of the virulence genes stx2 and eae in STEC from patients with gastroenteritis. In Germany, the proportion of serogroup O157 is substantially higher among STEC isolates from patients with haemolytic uraemic syndrome (HUS) than among STEC isolates from patients with gastroenteritis. The reason for this is unknown. Independent of serogroup, the virulence genes stx2 and eae have been associated with severe disease. Data collected in 2000–2001 from a Germany-wide laboratory-based surveillance system for STEC-associated gastroenteritis in patients <15 years were analysed. Overall, 18% of the STEC isolates belonged to serogroup O157. Compared with non-O157 strains, 0157 isolates were strongly associated with the simultaneous presence of both an stx2 gene and the eae gene (OR, 76; 95%CI, 27–230). Within the subset of STEC isolates that carried both virulence genes, 60% belonged to serogroup O157, a proportion similar to that found in STEC isolates from pediatric patients with HUS in Germany and Austria (67%, P=0.35). These data suggest that the more frequent carriage of both virulence genes, i.e. stx2 and eae, forms the basis of why STEC O157 predominates in patients with HUS.

References

  1. 1.
    Gerber A, Karch H, Allerberger F, et al (2002) Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis 186:493–500CrossRefPubMedGoogle Scholar
  2. 2.
    Robert-Koch-Institut: Erkrankung durch enterohämorrhagische Escherichia coli Stämme (EHEC) (2001) In: RKI (ed) Infektionsepidemiologisches Jahrbuch meldefplichtiger Krankheiten für 2001. Mercedes-Druck, Berlin. pp 53Google Scholar
  3. 3.
    Banatvala N, Griffin PM, Greene KD, et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMedGoogle Scholar
  4. 4.
    Fey PD, Wickert RS, Rupp ME, et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrhoeal stool samples from Nebraska. Emerg Infect Dis 6:530–533PubMedGoogle Scholar
  5. 5.
    Acheson DW, Frankson K, Willis D (1998) Multicenter prevalence study of Shiga toxin-producing Escherichia coli. In: Abstracts of the 98th General Meeting for the American Society for Microbiology. American Society for Microbiology, Washington DC, Abstract C-205Google Scholar
  6. 6.
    Cornick NA, Jelacic S, Ciol MA, et al (2002) Escherichia coli O157:H7 infections: discordance between filterable fecal Shiga toxin and disease outcome. J Infect Dis 186:57–63PubMedGoogle Scholar
  7. 7.
    Louise CB, Obrig TG (1995) Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397–1401Google Scholar
  8. 8.
    Tesh VL, Burris JA, Owens JW, et al (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392–3402PubMedGoogle Scholar
  9. 9.
    Barrett TJ, Potter ME, Strockbine NA (1990) Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 9:95–103PubMedGoogle Scholar
  10. 10.
    Siegler RL, Obrig TG, Pysher TJ, et al (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92–96PubMedGoogle Scholar
  11. 11.
    Ostroff SM, Tarr PI, Neill MA, et al (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160:994–998PubMedGoogle Scholar
  12. 12.
    Boerlin P, McEwen SA, Boerlin-Petzold F, et al (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497–503PubMedGoogle Scholar
  13. 13.
    Zimmerhackl LB (2003) Epidemiology of haemolytic uraemic syndrome in childhood. In: Abstracts of the 5th International Symposium on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections, Edinburgh, Abstract O46Google Scholar
  14. 14.
    Werber D, Ammon A (2000) Development of a research network for emerging foodborne pathogens in Germany. Euro Surveill 5:120–123PubMedGoogle Scholar
  15. 15.
    Fruth A, Richter H, Timm M, et al (2000) Zur Verbesserung der gegenwärtigen bakteriologischen Diagnostik von enterohämorrhagischen Escherichia coli (EHEC). Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 43:310–317Google Scholar
  16. 16.
    Ørskov F, Ørskov I (1984) Serotyping of Escherichia coli. Methods Microbiol 14:43–112Google Scholar
  17. 17.
    Cebula TA, Payne WL, Feng P (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 33:248–250PubMedGoogle Scholar
  18. 18.
    Schmidt H, Russmann H, Karch H (1993) Virulence determinants in nontoxinogenic Escherichia coli O157 strains that cause infantile diarrhea. Infect Immun 61:4894–4898PubMedGoogle Scholar
  19. 19.
    Beutin L, Geier D, Zimmermann S, et al (1995) Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 33:631–635PubMedGoogle Scholar
  20. 20.
    Willshaw GA, Scotland SM, Smith HR, et al (1992) Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis 166:797–802PubMedGoogle Scholar
  21. 21.
    Coimbra RS, Grimont F, Lenormand P, et al (2000) Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP). Res Microbiol 151:639–654CrossRefPubMedGoogle Scholar
  22. 22.
    Eklund M, Leino K, Siitonen A (2002) Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 40:4585–4593CrossRefPubMedGoogle Scholar
  23. 23.
    Karch H, Schmidt H, Brunder W (1998) Plasmid-encoded determinants of Escherichia coli O157:H7. In: Kaper JB, O’Brien A (eds) Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington DC, pp 183–194Google Scholar
  24. 24.
    Friedrich AW, Bielaszewska M, Zhang WL, et al (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74–84PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • D. Werber
    • 1
  • A. Fruth
    • 2
  • U. Buchholz
    • 1
  • R. Prager
    • 2
  • M. H. Kramer
    • 1
    • 3
  • A. Ammon
    • 1
  • H. Tschäpe
    • 2
  1. 1.Department for Infectious Disease EpidemiologyRobert Koch-InstitutBerlinGermany
  2. 2.National Reference Centre for Salmonella and Other Bacterial Enteric PathogensRobert Koch-InstitutWernigerodeGermany
  3. 3.Referat 325Bundesministerium für Gesundheit und Soziale SicherungBonnGermany

Personalised recommendations